secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2023-11-30T23:59:59+00:00
Accession:  0000105770-23-000075
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West Pharmaceutical extends butyl polymer supply agreement with ExxonMobil through 2028
--------------------------------------------------------------------------------

- Amendment secures supply of butyl polymers, a key raw material for pharmaceutical packaging, from 2024 to 2028.
- Pricing includes base price plus adjustments based on Brent crude, UK natural gas, and USGC isobutylene indices (redacted).
- Product qualification at Baton Rouge plant waives isobutylene adjustment during contract term as incentive.
- New sustainability collaboration provision added, with joint discussions on activities and milestones.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577023000075/0000105770-23-000075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577023000075/wst-20231127.htm
  HTML page:      https://secwatch.observer/filing/0000105770-23-000075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer